ArticleBJPsych open2021

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study.

Sanne Y Smith-Apeldoorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.